Vasa previa: when antenatal diagnosis can change fetal prognosis
Author:
Sutera Miriam1, Garofalo Anna1ORCID, Pilloni Eleonora1, Parisi Silvia1, Alemanno Maria Grazia1, Menato Guido1, Sciarrone Andrea1, Viora Elsa1
Affiliation:
1. Gynecology and Obstetrics Unit, Prenatal Diagnosis Ultrasound Center , Sant’Anna Hospital, Città della Salute e della Scienza, University of Turin , Turin , Italy
Abstract
Abstract
Objectives
Evaluate ultrasound diagnostic accuracy, maternal−fetal characteristics and outcomes in case of vasa previa diagnosed antenatally, postnatally or with spontaneous resolution before delivery.
Methods
Monocentric retrospective study enrolling women with antenatal or postnatal diagnosis of vasa previa at Sant’Anna Hospital in Turin from 2007 to 2018. Vasa previa were defined as fetal vessels that lay 2 cm within the uterine internal os using 2D and Color Doppler transvaginal ultrasound. Diagnosis was confirmed at delivery and on histopathological exam. Vasa previa with spontaneous resolutions were defined as fetal vessels that migrate >2 cm from uterine internal os during scheduled ultrasound follow-ups in pregnancy.
Results
We enrolled 29 patients (incidence of 0.03%). Ultrasound antenatally diagnosed 25 vasa previa (five had a spontaneous resolution) while four were diagnosed postnatally, with an overall sensitivity of 96.2%, specificity of 100%, positive predictive value of 96.2%, and negative predictive value of 100%. Early gestational age at diagnosis is significally associate with spontaneously resolution (p 0.023; aOR 1.63; 95% IC 1.18–2.89). Nearly 93% of our patient had a risk factor for vasa previa: placenta previa at second trimester or low-lying placenta, bilobated placenta, succenturiate cotyledon, velametous cord insertion or assisted reproduction technologies.
Conclusions
Maternal and fetal outcomes in case of vasa previa antenatally diagnosed are significally improved. Our data support the evaluation of umbilical cord insertion during routine second trimester ultrasound and a targeted screening for vasa previa in women with risk factor: it allows identification of fetus at high risk, reducing fetal mortality in otherwise healthy newborns.
Publisher
Walter de Gruyter GmbH
Subject
Obstetrics and Gynaecology,Pediatrics, Perinatology, and Child Health
Reference30 articles.
1. Jauniaux, ER, Alfirevic, Z, Bhide, AG, Burton, GJ, Collins, SL, Silver, R. Vasa praevia: diagnosis and management. Green-top guideline no. 27b. BJOG 2019;126:e49-61. https://doi.org/10.1111/1471-0528.15307. 2. Oyelese, Y, Catanzarite, V, Prefumo, F, Lashley, S, Schachter, M, Tovbin, Y, et al.. Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol 2004;103:937–42. https://doi.org/10.1097/01.aog.0000123245.48645.98. 3. Hasegawa, J, Nakamura, M, Ichizuka, K, Matsuoka, R, Sekizawa, A, Okai, T. Vasa previa is not infrequent. J Matern Fetal Neonatal Med 2012;25:2795–6. https://doi.org/10.3109/14767058.2012.712570. 4. Ruiter, L, Kok, N, Limpens, J, Derks, JB, De Graaf, IM, Mol, BW, et al.. Systematic review of accuracy of ultrasound in the diagnosis of vasa previa. Ultrasound Obstet Gynecol 2015;45:516–22. https://doi.org/10.1002/uog.14752. 5. Melcer, Y, Maymon, R, Jauniaux, ER. Vasa previa: prenatal diagnosis and management. Curr Opin Obstet Gynecol 2018;30:385–91. https://doi.org/10.1097/gco.0000000000000478.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|